RxDoctor Payments Data

Patricia Henry

Gastroenterology · Urbana, ILNPI 1629308663

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (56.0%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 15 manufacturers reported payments, led by Pinnacle Biologics, Inc at 51.4% of the total. Reporting peaked in 2022 at $2,235 and has fallen 81.0% since, to $425 in 2025.

$3,790in general payments, 2019–2025

Across 45 payments — averaging $84.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pinnacle Biologics, Inc$2K
  • AbbVie$639
  • Conmed Corporation$306
  • Medtronic$247
  • Boston Scientific$182
  • Phathom Pharmaceuticals, Inc.$116
  • plus $354 from 9 others
$437,013in research payments, 2019–2025

Across 174 payments — averaging $2511.57 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Janssen Research & Development, LLC$301K
  • Regeneron$84K
  • AbbVie$50K
  • Takeda Pharmaceuticals U.S.A., Inc.$3K

What the payments were for

  • Speaking & faculty fees$1,00026%
  • Travel & lodging$66718%
  • Food & beverage$2,12356%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,790 in reported general payments places this provider in the 70th percentile of 787 gastroenterology providers in Illinois.

See all gastroenterology providers in Illinois

Most prescribed under Part D

DrugClaimsCost to plans & patients
Alosetron Hcl13$8,814
Omeprazole37$885
Pantoprazole Sodium23$303

Paid to pharmacies, not to this prescriber.

Other gastroenterology in Urbana

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →